Skip to main content
. 2011 Mar 22;6(3):e17929. doi: 10.1371/journal.pone.0017929

Figure 6. PDGF modulated TGFβ-Activin Receptor-like Kinases (ALKs) signaling pathways in MCs.

Figure 6

(A, B) MCs were treated with neutralizing antibody for TGFβ (10 µg/ml) (NA) or control normal IgY (CTL) for 24 h prior to treatment with PDGF at indicated concentrations for 24 h. Equal amounts of cell lysates were subjected to Western blot. One of three independent experiments is shown.